Cresco Labs (XCNQ:CL) Notes Receivable: C$0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XCNQ:CL Cresco Labs Inc XCNQ:CL
61 GF Score
Price C$0.96
GF Value C$1.47
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Cresco Labs Notes Receivable?

Cresco Labs XCNQ:CL +1.05% 61 Notes Receivable is C$0.0 Mil as of Mar. 2026. GuruFocus rates XCNQ:CL with a GF Score™ of 61/100 and a GF Value™ of C$1.47 (Possible Value Trap). The stock has 5 warning signs investors should review.

Cresco Labs's Notes Receivable for the quarter that ended in Mar. 2026 was C$0.0 Mil.

Cresco Labs Notes Receivable Historical Data

* Premium members only.

The historical data trend for Cresco Labs's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Notes Receivable Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cresco Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XCNQ:CL
61GF Score
Cresco Labs Inc XCNQ:CL
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of C$0.0 Mil mean?
Cresco Labs (XCNQ:CL) has a Notes Receivable of C$0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Cresco Labs and its competitors.
Is Cresco Labs' Notes Receivable too high?
Cresco Labs' current Notes Receivable is C$0.0 Mil. Overall, Cresco Labs has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cresco Labs' Notes Receivable compare to ZTS and UTHR?
Cresco Labs' Notes Receivable of C$0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Cresco Labs and its competitors. Cresco Labs's current Notes Receivable is C$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cresco Labs stock overvalued right now?
Based on GuruFocus' analysis, Cresco Labs (XCNQ:CL) is currently considered Possible Value Trap. The stock's GF Value™ is C$1.47, compared to a current price of C$0.96 — trading 34.7% below its estimated fair value. The current Notes Receivable is C$0.0 Mil. Cresco Labs' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Cresco Labs (XCNQ:CL), the current Notes Receivable is C$0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cresco Labs (XCNQ:CL) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of C$0.96 is trading 34.7% below its estimated GF Value™ of C$1.47. GuruFocus considers Cresco Labs to be Possible Value Trap.

Key valuation signals for XCNQ:CL:

  • Notes Receivable: C$0.0 Mil
  • GF Value™: C$1.47 vs. price of C$0.96 (34.7% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the XCNQ:CL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cresco Labs Business Description

Other Exchanges CRLBF:USA6CQ:Germany
Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
61GF Score

Get the complete analysis for XCNQ:CL

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.96
Price
C$1.47
GF Value